Bangkok Genomics Innovation PCL (BKK:BKGI)
Thailand flag Thailand · Delayed Price · Currency is THB
1.610
-0.030 (-1.83%)
Sep 23, 2025, 4:29 PM ICT

BKK:BKGI Income Statement

Millions THB. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022
Period Ending
Jun '25 Dec '24 Dec '23 Dec '22
331.82337.59245.39304.77
Revenue Growth (YoY)
26.27%37.57%-19.48%-
Cost of Revenue
194.68197.52129.29147.26
Gross Profit
137.14140.08116.1157.52
Selling, General & Admin
104.0394.585.2293.97
Other Operating Expenses
-9.73-8.27-1.95-15.29
Operating Expenses
95.4487.6182.5277.78
Operating Income
41.752.4633.5879.73
Interest Expense
-1.39-1.36-1.64-1.07
Earnings From Equity Investments
-0.31-0.08--
Pretax Income
39.9951.0231.9478.66
Income Tax Expense
0.90.86-0.23.54
Earnings From Continuing Operations
39.150.1632.1475.11
Minority Interest in Earnings
0.030.01--
Net Income
39.1350.1732.1475.11
Net Income to Common
39.1350.1732.1475.11
Net Income Growth
5.48%56.09%-57.21%-
Shares Outstanding (Basic)
600567440214
Shares Outstanding (Diluted)
600567440214
Shares Change (YoY)
23.23%28.91%105.72%-
EPS (Basic)
0.070.090.070.35
EPS (Diluted)
0.070.090.070.35
EPS Growth
-14.41%21.09%-79.20%-
Free Cash Flow
-12.91-23.4667.0353.9
Free Cash Flow Per Share
-0.02-0.040.150.25
Dividend Per Share
0.0500.0500.0544.666
Dividend Growth
--8.26%-98.83%-
Gross Margin
41.33%41.49%47.31%51.68%
Operating Margin
12.57%15.54%13.69%26.16%
Profit Margin
11.79%14.86%13.10%24.64%
Free Cash Flow Margin
-3.89%-6.95%27.31%17.68%
EBITDA
56.0564.8344.1688.82
EBITDA Margin
16.89%19.20%18.00%29.14%
D&A For EBITDA
14.3512.3710.579.08
EBIT
41.752.4633.5879.73
EBIT Margin
12.57%15.54%13.69%26.16%
Effective Tax Rate
2.24%1.69%-4.51%
Revenue as Reported
331.82337.59245.39304.77
Source: S&P Global Market Intelligence. Standard template. Financial Sources.